Gene expression profile of amyloid beta protein-injected mouse model for Alzheimer disease

Acta Pharmacol Sin. 2005 Jun;26(6):666-72. doi: 10.1111/j.1745-7254.2005.00129.x.

Abstract

Aim: To investigate the gene expression profile changes in the cerebral cortex of mice injected icv with amyloid beta-protein (Abeta) fragment 25-35 using cDNA microarray.

Methods: Balb/c mice were randomly divided into a control group and Abeta-treated group. The Morris water maze test was performed to detect the effect of Abeta-injection on the learning and memory of mice. Atlas Mouse 1.2 Expression Arrays containing 1176 genes were used to investigate the gene expression pattern of each group.

Results: The gene expression profiles showed that 19 genes including TBX1, NF-kB, AP-1/c-Jun, cadherin, integrin, erb-B2, and FGFR1 were up-regulated after 2 weeks of icv administration of Abeta; while 12 genes were down-regulated, including NGF, glucose phosphate isomerase 1, AT motif binding factor 1, Na+/K+-ATPase, and Akt.

Conclusions: The results provide important leads for pursuing a more complete understanding of the molecular events of Abeta-injection into mice with Alzheimer disease.

MeSH terms

  • Alzheimer Disease / chemically induced
  • Alzheimer Disease / genetics*
  • Amyloid beta-Peptides
  • Animals
  • Cerebral Cortex / metabolism*
  • Gene Expression Profiling*
  • Male
  • Maze Learning*
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B / metabolism
  • Nerve Growth Factor / metabolism
  • Oligonucleotide Array Sequence Analysis
  • Peptide Fragments
  • T-Box Domain Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • NF-kappa B
  • Peptide Fragments
  • T-Box Domain Proteins
  • TBX1 protein, human
  • amyloid beta-protein (25-35)
  • Nerve Growth Factor